Revenue operations: the complete 2026 guide for healthcare and life sciences in Latin America

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in Latin America. In this market, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms, so the way you install revenue operations has to be shaped to that reality from day one.

In 2026, revenue operations is the function that owns the pipes between marketing, sales, and success. If you are building a B2B revenue engine this year, you cannot afford to treat it as optional.

The reason revenue operations matters more now than at any point in the last decade is straightforward: growth stalls when systems, data, and process drift. That change is compounding month over month, and the teams that installed it early are pulling away.

The mechanics are not complicated. You need a target list narrow enough to be recognisable, an operating rhythm short enough to catch drift within a week, and a north-star metric — for revenue operations, that is days-to-close and forecast accuracy — reviewed every Monday.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in Latin America it is compounded by the fact that local partnership depth, not marketing spend is what actually gates growth. Revenue operations is only useful here when it is pointed at both constraints at once.

Most teams that fail at revenue operations fail the same way: hiring RevOps to fix CRM instead of to own revenue. Every consequence downstream — bad conversion, dead pipeline, burned reputation — traces back to that root cause.

The install curve looks like this. Weeks one and two are diagnosis and instrumentation. Weeks three through six are the first live cycle at deliberately low volume. Weeks seven through twelve are the ramp. By day 90 you should be reading the metric out loud in every leadership meeting.

You do not need a large team to run revenue operations. You need one owner with authority, one operator with the tools, and a weekly review that is not allowed to slip. Everything else — vendors, seats, decks — is negotiable.

A working revenue operations function is worth more than the sum of any three point tools you could buy in its place. Once it compounds, you stop asking whether it works and start asking where to put the next dollar. That is the goal.

Concretely for healthcare and life sciences in Latin America: the healthcare teams that install this get past procurement instead of dying in it, and one properly-installed LATAM account becomes a reference across the region. That is the reason it is worth installing revenue operations deliberately for this market rather than importing a playbook designed for somewhere else.